Lysogene Aktie
Personal
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 12 | 14 | 18 | 23 | 23 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,00 | 0,26 | 0,74 | 0,58 | 0,16 |
Bilanz (in Mio. EUR) - Aktiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 18 | 26 | 34 | 26 | 18 |
| Summe Anlagevermögen | 1 | 3 | 2 | 2 | 2 |
| Summe Aktiva | 18 | 29 | 36 | 28 | 20 |
Bilanz (in Mio. EUR) - Passiva
| 2017 | 2018 | 2019 | 2020 | 2021 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 4 | 22 | 34 | 22 | 24 |
| Summe Eigenkapital | 14 | 6 | 3 | 7 | -4 |
| Summe Passiva | 18 | 29 | 36 | 28 | 20 |
Adresse
| 18-20, rue Jacques Dulud, 92200 Paris | |
| Telefon | +33 (1) 41-43-03-90 |
| Internet | http://www.lysogene.com |
Management
|
Carole Deffez
Independent Non-Executive Director |
|
Céline Fantin
Independent Non-Executive Director |
|
Côme de La Tour du Pin
Chief Financial Officer |
|
Karen Pignet-Aiach
Chairman & Chief Executive Officer |
|
Marie Deneux
Chief Regulatory Officer |
|
Marie Trad
Chief Medical Officer |
|
Michel Picot
Independent Non-Executive Director |
|
Peter Lichtlen
Independent Non-Executive Director |
|
Ralph Laufer
Chief Scientific Officer |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.